Search Results - "Grubitzsch, H."

Refine Results
  1. 1

    Insight into the incidence of acute aortic dissection in the German region of Berlin and Brandenburg by Kurz, S.D, Falk, V, Kempfert, J, Gieb, M, Ruschinski, T.M, Kukucka, M, Tsokos, M, Grubitzsch, H, Herbst, H, Semmler, J, Buschmann, C

    Published in International journal of cardiology (15-08-2017)
    “…Abstract Background Stanford acute type A aortic dissection (ATAAD) is a potentially lethal condition. Epidemiology studies show a statistical incidence in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Prävention und Behandlung der Mediastinitis by Grubitzsch, H.

    “…Originalpublikation Abu-Omar Y, Kocher GJ, Bosco P et al (2017) European Association for Cardio-Thoracic Surgery expert consensus statement on the prevention…”
    Get full text
    Journal Article
  4. 4

    Feasibility and influence of hTEE monitoring on postoperative management in cardiac surgery patients by Treskatsch, S., Balzer, F., Knebel, F., Habicher, M., Braun, J. P., Kastrup, M., Grubitzsch, H., Wernecke, K.-D., Spies, C., Sander, M.

    “…Monoplane hemodynamic TEE (hTEE) monitoring (ImaCor ® ClariTEE ® ) might be a useful alternative to continuously evaluate cardiovascular function and we aimed…”
    Get full text
    Journal Article
  5. 5

    An Electronic Tool for Visual Feedback to Monitor the Adherence to Quality Indicators in Intensive Care Medicine by Kastrup, M, Nolting, MJ, Ahlborn, R, Braun, J-P, Grubitzsch, H, Wernecke, K-D, Spies, C

    Published in Journal of international medical research (01-12-2011)
    “…Evidence-based medicine is often inadequately implemented in intensive care units (ICU); the aim of this study was to improve its implementation via a…”
    Get full text
    Journal Article
  6. 6

    Recombinant activated factor VII for treatment of refractory hemorrhage after surgery for acute aortic dissection by Grubitzsch, H, Vargas-Hein, O, Von Heymann, C, Konertz, W

    Published in Journal of cardiovascular surgery (01-08-2009)
    “…Despite appropriate treatment, surgery for aortic dissection is frequently associated with bleeding problems. In these series we report on the employment of…”
    Get full text
    Journal Article
  7. 7

    Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss by von Heymann, C, Redlich, U, Moritz, M, Sander, M, Vargas Hein, O, Grubitzsch, H, Konertz, W F, Spies, C

    Published in The Thoracic and cardiovascular surgeon (01-12-2005)
    “…Platelet aggregation inhibitors, such as aspirin and clopidogrel, are associated with increased bleeding in patients undergoing cardiac surgery with…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Single Center Experience with Short-term Circulatory Support: A Comparison of Demography, Indication and Clinical Outcome Over the Past Decade by Linneweber, J., Swojanowsky, P., Dohmen, P., Grubitzsch, H., Dushe, S., Holinski, S., Konertz, W.

    Published in Open journal of cardiovascular surgery (15-10-2010)
    “…J. Linneweber, P. Swojanowsky, P. Dohmen, H. Grubitzsch, S. Dushe, S. Holinski and W. KonertzKlinik für kardiovaskuläre Chirurgie Charité-Universitätsmedizin…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: a rationale for the use of coagulation factor concentrates? by von Heymann, C, Schoenfeld, H, Sander, M, Ziemer, S, Grubitzsch, H, Spies, C

    Published in The Heart surgery forum (2005)
    “…Clopidogrel, an irreversible ADP-receptor antagonist, inhibits platelet aggregation mediated by reduced activation of glycoprotein receptor IIb/IIIa…”
    Get more information
    Journal Article
  13. 13

    Effects of doxorubicin and ibrutinib on atrial arrhythmogenity: ex-vivo assessment in human myocardium by Berger, Y, Primessnig, U, Huettemeister, J, Parwani, A S, Boldt, L H, Pieske, B, Falk, V, Grubitzsch, H, Blaschke, F, Heinzel, F R

    Published in European heart journal (03-10-2022)
    “…Abstract Introduction The cytostatic drugs doxorubicin (Dox) and ibrutinib (Ibr) are established in the treatment of various tumor diseases. In (pre-) clinical…”
    Get full text
    Journal Article
  14. 14

    Impact of implantation technique on hemodynamic results of the Pericarbon Freedom stentless valve by Beholz, S, Grubitzsch, H, Dushe, S, Liu, J, Dohmen, P M, Konertz, W

    Published in The Thoracic and cardiovascular surgeon (01-08-2005)
    “…The Pericarbon Freedom stentless valve has shown excellent hemodynamic results in the midterm course. However, there is no information as to whether a…”
    Get more information
    Journal Article
  15. 15

    Bleeding after cardiac surgery: the role of recombinant factor VIIa by von Heymann, C, Spies, C, Grubitzsch, H, Schönfeld, H, Sander, M, Volk, Th

    Published in Hämostaseologie (01-08-2006)
    “…Cardiac surgery carries a remarkable risk of blood loss requiring transfusion of blood products. Moreover, severe bleeding necessitating reoperation occurs in…”
    Get more information
    Journal Article
  16. 16

    Inferior Caval Valve Implantation Versus Optimal Medical Therapy for Severe Tricuspid Regurgitation by Laule, Michael, Mattig, Isabel, Schöbel, Christoph, Knebel, Fabian, Lauten, Alexander, Lembcke, Alexander, Thoenes, Martin, Grubitzsch, Herko, Stangl, Karl, Dreger, Henryk

    “…To compare the effect of CAVI on exercise capacity and symptom relief with optimal medical therapy (OMT), we conducted the investigator-initiated, randomized…”
    Get full text
    Journal Article
  17. 17

    Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion by Beholz, S, Grubitzsch, H, Bergmann, B, Wollert, H G, Eckel, L

    Published in The Thoracic and cardiovascular surgeon (01-10-1999)
    “…Extracorporeal circulation forces complete anticoagulation, most frequently achieved by complete heparinization. Activated clotting time (ACT) is the gold…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    068-ICLINICAL AND HAEMODYNAMIC OUTCOMES IN 804 PATIENTS RECEIVING THE FREEDOM SOLO STENTLESS AORTIC VALVE: RESULTS FROM AN INTERNATIONAL PROSPECTIVE MULTICENTRE STUDY by Grubitzsch, H., Wang, S., Matschke, K., Glauber, M., Heimansohn, D., Tan, E., Francois, K., Thalmann, M.

    “…Objectives: The aim of this prospective, non-randomised, multicentre trial was to demonstrate the safety and effectiveness of the Freedom SOLO valve. Methods:…”
    Get full text
    Journal Article